Innate Pharma (IPHA) Other Working Capital Changes (2019 - 2024)
Innate Pharma (IPHA) posted quarterly Other Working Capital Changes of -$333420.6 for Q4 2024, up 69.67% year-on-year from -$196512.7 in Q1 2024, and up 69.67% on a QoQ basis from -$1.1 million in Q4 2023.
Innate Pharma (IPHA) Other Working Capital Changes (2019 - 2024) Analysis & Trends
Innate Pharma (IPHA) has reported Other Working Capital Changes for 3 consecutive years, with -$333420.6 the latest figure, recorded in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innate Pharma | 157.68 Mn | 157.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -333,420.60 |
| Dec 31, 2024 | -333,420.60 |
| Dec 31, 2024 | -333,420.60 |
| Dec 31, 2023 | -1.10 Mn |
| Dec 31, 2023 | -1.10 Mn |
| Dec 31, 2023 | -1.10 Mn |
| Dec 31, 2019 | -550,769.87 |
| Dec 31, 2019 | -550,769.87 |
| Dec 31, 2019 | -550,769.87 |